Syndax Pharmaceuticals SNDX is gearing up to announce its quarterly earnings on Tuesday, 2024-11-05. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Syndax Pharmaceuticals will report an earnings per share (EPS) of $-1.11.
Investors in Syndax Pharmaceuticals are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Earnings Track Record
Last quarter the company beat EPS by $0.11, which was followed by a 4.36% drop in the share price the next day.
Here's a look at Syndax Pharmaceuticals's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.91 | -0.98 | -0.99 | -0.78 |
| EPS Actual | -0.80 | -0.85 | -1 | -0.73 |
| Price Change % | -4.0% | -2.0% | -2.0% | 0.0% |
Tracking Syndax Pharmaceuticals's Stock Performance
Shares of Syndax Pharmaceuticals were trading at $18.98 as of November 01. Over the last 52-week period, shares are up 30.34%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for Syndax Pharmaceuticals visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
